Global Postmenopausal Vaginal Atrophy Drugs Sales Market Report 2021

Global Postmenopausal Vaginal Atrophy Drugs Sales Market Report 2021

Table of Contents
1 Postmenopausal Vaginal Atrophy Drugs Market Overview
1.1 Postmenopausal Vaginal Atrophy Drugs Product Scope
1.2 Postmenopausal Vaginal Atrophy Drugs Segment by Type
1.2.1 Global Postmenopausal Vaginal Atrophy Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Premarin
1.2.3 Vagifem
1.2.4 Estrace
1.2.5 Estring
1.2.6 Femring
1.3 Postmenopausal Vaginal Atrophy Drugs Segment by Application
1.3.1 Global Postmenopausal Vaginal Atrophy Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Vaginal Gels
1.3.3 Creams
1.3.4 Tablets
1.3.5 Rings
1.3.6 Patches
1.4 Postmenopausal Vaginal Atrophy Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Postmenopausal Vaginal Atrophy Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Postmenopausal Vaginal Atrophy Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Postmenopausal Vaginal Atrophy Drugs Price Trends (2016-2027)
2 Postmenopausal Vaginal Atrophy Drugs Estimates and Forecasts by Region
2.1 Global Postmenopausal Vaginal Atrophy Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Postmenopausal Vaginal Atrophy Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Postmenopausal Vaginal Atrophy Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Postmenopausal Vaginal Atrophy Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Postmenopausal Vaginal Atrophy Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Postmenopausal Vaginal Atrophy Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Postmenopausal Vaginal Atrophy Drugs Estimates and Projections (2016-2027)
2.4.3 China Postmenopausal Vaginal Atrophy Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Postmenopausal Vaginal Atrophy Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Postmenopausal Vaginal Atrophy Drugs Estimates and Projections (2016-2027)
2.4.6 India Postmenopausal Vaginal Atrophy Drugs Estimates and Projections (2016-2027)
3 Global Postmenopausal Vaginal Atrophy Drugs Competition Landscape by Players
3.1 Global Top Postmenopausal Vaginal Atrophy Drugs Players by Sales (2016-2021)
3.2 Global Top Postmenopausal Vaginal Atrophy Drugs Players by Revenue (2016-2021)
3.3 Global Postmenopausal Vaginal Atrophy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Postmenopausal Vaginal Atrophy Drugs as of 2020)
3.4 Global Postmenopausal Vaginal Atrophy Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Postmenopausal Vaginal Atrophy Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Postmenopausal Vaginal Atrophy Drugs Market Size by Type
4.1 Global Postmenopausal Vaginal Atrophy Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Postmenopausal Vaginal Atrophy Drugs Price by Type (2016-2021)
4.2 Global Postmenopausal Vaginal Atrophy Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Postmenopausal Vaginal Atrophy Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Postmenopausal Vaginal Atrophy Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Postmenopausal Vaginal Atrophy Drugs Price Forecast by Type (2022-2027)
5 Global Postmenopausal Vaginal Atrophy Drugs Market Size by Application
5.1 Global Postmenopausal Vaginal Atrophy Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Postmenopausal Vaginal Atrophy Drugs Price by Application (2016-2021)
5.2 Global Postmenopausal Vaginal Atrophy Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Postmenopausal Vaginal Atrophy Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Postmenopausal Vaginal Atrophy Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Postmenopausal Vaginal Atrophy Drugs Price Forecast by Application (2022-2027)
6 North America Postmenopausal Vaginal Atrophy Drugs Market Facts & Figures
6.1 North America Postmenopausal Vaginal Atrophy Drugs Sales by Company
6.1.1 North America Postmenopausal Vaginal Atrophy Drugs Sales by Company (2016-2021)
6.1.2 North America Postmenopausal Vaginal Atrophy Drugs Revenue by Company (2016-2021)
6.2 North America Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Type
6.2.1 North America Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Application
6.3.1 North America Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Application (2022-2027)
7 Europe Postmenopausal Vaginal Atrophy Drugs Market Facts & Figures
7.1 Europe Postmenopausal Vaginal Atrophy Drugs Sales by Company
7.1.1 Europe Postmenopausal Vaginal Atrophy Drugs Sales by Company (2016-2021)
7.1.2 Europe Postmenopausal Vaginal Atrophy Drugs Revenue by Company (2016-2021)
7.2 Europe Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Type
7.2.1 Europe Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Application
7.3.1 Europe 138 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 138 Sales Breakdown by Application (2022-2027)
8 China Postmenopausal Vaginal Atrophy Drugs Market Facts & Figures
8.1 China Postmenopausal Vaginal Atrophy Drugs Sales by Company
8.1.1 China Postmenopausal Vaginal Atrophy Drugs Sales by Company (2016-2021)
8.1.2 China Postmenopausal Vaginal Atrophy Drugs Revenue by Company (2016-2021)
8.2 China Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Type
8.2.1 China Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Type (2022-2027)
8.3 China Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Application
8.3.1 China 243 Sales Breakdown by Application (2016-2021)
8.3.2 China 243 Sales Breakdown by Application (2022-2027)
9 Japan Postmenopausal Vaginal Atrophy Drugs Market Facts & Figures
9.1 Japan Postmenopausal Vaginal Atrophy Drugs Sales by Company
9.1.1 Japan Postmenopausal Vaginal Atrophy Drugs Sales by Company (2016-2021)
9.1.2 Japan Postmenopausal Vaginal Atrophy Drugs Revenue by Company (2016-2021)
9.2 Japan Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Type
9.2.1 Japan Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Postmenopausal Vaginal Atrophy Drugs Market Facts & Figures
10.1 Southeast Asia Postmenopausal Vaginal Atrophy Drugs Sales by Company
10.1.1 Southeast Asia Postmenopausal Vaginal Atrophy Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Postmenopausal Vaginal Atrophy Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Postmenopausal Vaginal Atrophy Drugs Market Facts & Figures
11.1 India Postmenopausal Vaginal Atrophy Drugs Sales by Company
11.1.1 India Postmenopausal Vaginal Atrophy Drugs Sales by Company (2016-2021)
11.1.2 India Postmenopausal Vaginal Atrophy Drugs Revenue by Company (2016-2021)
11.2 India Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Type
11.2.1 India Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Type (2022-2027)
11.3 India Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Application
11.3.1 India Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Postmenopausal Vaginal Atrophy Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Postmenopausal Vaginal Atrophy Drugs Business
12.1 Actavis plc
12.1.1 Actavis plc Corporation Information
12.1.2 Actavis plc Business Overview
12.1.3 Actavis plc Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Actavis plc Postmenopausal Vaginal Atrophy Drugs Products Offered
12.1.5 Actavis plc Recent Development
12.2 Bionovo, Inc.
12.2.1 Bionovo, Inc. Corporation Information
12.2.2 Bionovo, Inc. Business Overview
12.2.3 Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Products Offered
12.2.5 Bionovo, Inc. Recent Development
12.3 Endoceutics, Inc.
12.3.1 Endoceutics, Inc. Corporation Information
12.3.2 Endoceutics, Inc. Business Overview
12.3.3 Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Products Offered
12.3.5 Endoceutics, Inc. Recent Development
12.4 Novo Nordisk A/S
12.4.1 Novo Nordisk A/S Corporation Information
12.4.2 Novo Nordisk A/S Business Overview
12.4.3 Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Products Offered
12.4.5 Novo Nordisk A/S Recent Development
12.5 Pfizer Inc.
12.5.1 Pfizer Inc. Corporation Information
12.5.2 Pfizer Inc. Business Overview
12.5.3 Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Products Offered
12.5.5 Pfizer Inc. Recent Development
12.6 Teva Pharmaceuticals Ltd.
12.6.1 Teva Pharmaceuticals Ltd. Corporation Information
12.6.2 Teva Pharmaceuticals Ltd. Business Overview
12.6.3 Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Products Offered
12.6.5 Teva Pharmaceuticals Ltd. Recent Development
12.7 Therapeutics MD, Inc.
12.7.1 Therapeutics MD, Inc. Corporation Information
12.7.2 Therapeutics MD, Inc. Business Overview
12.7.3 Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Products Offered
12.7.5 Therapeutics MD, Inc. Recent Development
12.8 Shionogi & Company
12.8.1 Shionogi & Company Corporation Information
12.8.2 Shionogi & Company Business Overview
12.8.3 Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Products Offered
12.8.5 Shionogi & Company Recent Development
12.9 Allergan plc
12.9.1 Allergan plc Corporation Information
12.9.2 Allergan plc Business Overview
12.9.3 Allergan plc Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Allergan plc Postmenopausal Vaginal Atrophy Drugs Products Offered
12.9.5 Allergan plc Recent Development
12.10 Shionogi & Co. Ltd.
12.10.1 Shionogi & Co. Ltd. Corporation Information
12.10.2 Shionogi & Co. Ltd. Business Overview
12.10.3 Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Products Offered
12.10.5 Shionogi & Co. Ltd. Recent Development
13 Postmenopausal Vaginal Atrophy Drugs Manufacturing Cost Analysis
13.1 Postmenopausal Vaginal Atrophy Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Postmenopausal Vaginal Atrophy Drugs
13.4 Postmenopausal Vaginal Atrophy Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Postmenopausal Vaginal Atrophy Drugs Distributors List
14.3 Postmenopausal Vaginal Atrophy Drugs Customers
15 Market Dynamics
15.1 Postmenopausal Vaginal Atrophy Drugs Market Trends
15.2 Postmenopausal Vaginal Atrophy Drugs Drivers
15.3 Postmenopausal Vaginal Atrophy Drugs Market Challenges
15.4 Postmenopausal Vaginal Atrophy Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Postmenopausal Vaginal Atrophy Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Postmenopausal Vaginal Atrophy Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Postmenopausal Vaginal Atrophy Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Postmenopausal Vaginal Atrophy Drugs Sales (K Units) by Region (2016-2021)
Table 5. Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Postmenopausal Vaginal Atrophy Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Postmenopausal Vaginal Atrophy Drugs Revenue Share by Region (2016-2021)
Table 8. Global Postmenopausal Vaginal Atrophy Drugs Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Postmenopausal Vaginal Atrophy Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Postmenopausal Vaginal Atrophy Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Postmenopausal Vaginal Atrophy Drugs Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Postmenopausal Vaginal Atrophy Drugs Sales Share by Company (2016-2021)
Table 14. Global Postmenopausal Vaginal Atrophy Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Postmenopausal Vaginal Atrophy Drugs Revenue Share by Company (2016-2021)
Table 16. Global Postmenopausal Vaginal Atrophy Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postmenopausal Vaginal Atrophy Drugs as of 2020)
Table 17. Global Postmenopausal Vaginal Atrophy Drugs Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Postmenopausal Vaginal Atrophy Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Postmenopausal Vaginal Atrophy Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Postmenopausal Vaginal Atrophy Drugs Sales (K Units) by Type (2016-2021)
Table 22. Global Postmenopausal Vaginal Atrophy Drugs Sales Share by Type (2016-2021)
Table 23. Global Postmenopausal Vaginal Atrophy Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Postmenopausal Vaginal Atrophy Drugs Price (USD/Unit) by Type (2016-2021)
Table 25. Global Postmenopausal Vaginal Atrophy Drugs Sales Share by Type (2022-2027)
Table 26. Global Postmenopausal Vaginal Atrophy Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Postmenopausal Vaginal Atrophy Drugs Revenue Share by Type (2022-2027)
Table 28. Global Postmenopausal Vaginal Atrophy Drugs Price (USD/Unit) by Type (2022-2027)
Table 29. Global Postmenopausal Vaginal Atrophy Drugs Sales (K Units) by Application (2016-2021)
Table 30. Global Postmenopausal Vaginal Atrophy Drugs Sales Share by Application (2016-2021)
Table 31. Global Postmenopausal Vaginal Atrophy Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Postmenopausal Vaginal Atrophy Drugs Price (USD/Unit) by Application (2016-2021)
Table 33. Global Postmenopausal Vaginal Atrophy Drugs Sales (K Units) by Application (2022-2027)
Table 34. Global Postmenopausal Vaginal Atrophy Drugs Sales Share by Application (2022-2027)
Table 35. Global Postmenopausal Vaginal Atrophy Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Postmenopausal Vaginal Atrophy Drugs Revenue Share by Application (2022-2027)
Table 37. Global Postmenopausal Vaginal Atrophy Drugs Price (USD/Unit) by Application (2022-2027)
Table 38. North America Postmenopausal Vaginal Atrophy Drugs Sales (K Units) by Company (2016-2021)
Table 39. North America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Postmenopausal Vaginal Atrophy Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Postmenopausal Vaginal Atrophy Drugs Sales by Type (2016-2021) & (K Units)
Table 43. North America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Postmenopausal Vaginal Atrophy Drugs Sales by Type (2022-2027) & (K Units)
Table 45. North America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Postmenopausal Vaginal Atrophy Drugs Sales by Application (2016-2021) & (K Units)
Table 47. North America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Postmenopausal Vaginal Atrophy Drugs Sales by Application (2022-2027) & (K Units)
Table 49. North America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Postmenopausal Vaginal Atrophy Drugs Sales (K Units) by Company (2016-2021)
Table 51. Europe Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Postmenopausal Vaginal Atrophy Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Postmenopausal Vaginal Atrophy Drugs Sales by Type (2016-2021) & (K Units)
Table 55. Europe Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Postmenopausal Vaginal Atrophy Drugs Sales by Type (2022-2027) & (K Units)
Table 57. Europe Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Postmenopausal Vaginal Atrophy Drugs Sales by Application (2016-2021) & (K Units)
Table 59. Europe Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Postmenopausal Vaginal Atrophy Drugs Sales by Application (2022-2027) & (K Units)
Table 61. Europe Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Application (2022-2027)
Table 62. China Postmenopausal Vaginal Atrophy Drugs Sales (K Units) by Company (2016-2021)
Table 63. China Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Company (2016-2021)
Table 64. China Postmenopausal Vaginal Atrophy Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Postmenopausal Vaginal Atrophy Drugs Sales by Type (2016-2021) & (K Units)
Table 67. China Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Type (2016-2021)
Table 68. China Postmenopausal Vaginal Atrophy Drugs Sales by Type (2022-2027) & (K Units)
Table 69. China Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Type (2022-2027)
Table 70. China Postmenopausal Vaginal Atrophy Drugs Sales by Application (2016-2021) & (K Units)
Table 71. China Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Application (2016-2021)
Table 72. China Postmenopausal Vaginal Atrophy Drugs Sales by Application (2022-2027) & (K Units)
Table 73. China Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Postmenopausal Vaginal Atrophy Drugs Sales (K Units) by Company (2016-2021)
Table 75. Japan Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Postmenopausal Vaginal Atrophy Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Postmenopausal Vaginal Atrophy Drugs Sales by Type (2016-2021) & (K Units)
Table 79. Japan Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Postmenopausal Vaginal Atrophy Drugs Sales by Type (2022-2027) & (K Units)
Table 81. Japan Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Postmenopausal Vaginal Atrophy Drugs Sales by Application (2016-2021) & (K Units)
Table 83. Japan Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Postmenopausal Vaginal Atrophy Drugs Sales by Application (2022-2027) & (K Units)
Table 85. Japan Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Postmenopausal Vaginal Atrophy Drugs Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Postmenopausal Vaginal Atrophy Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Postmenopausal Vaginal Atrophy Drugs Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Postmenopausal Vaginal Atrophy Drugs Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Postmenopausal Vaginal Atrophy Drugs Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Postmenopausal Vaginal Atrophy Drugs Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Application (2022-2027)
Table 98. India Postmenopausal Vaginal Atrophy Drugs Sales (K Units) by Company (2016-2021)
Table 99. India Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Company (2016-2021)
Table 100. India Postmenopausal Vaginal Atrophy Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Postmenopausal Vaginal Atrophy Drugs Sales by Type (2016-2021) & (K Units)
Table 103. India Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Type (2016-2021)
Table 104. India Postmenopausal Vaginal Atrophy Drugs Sales by Type (2022-2027) & (K Units)
Table 105. India Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Type (2022-2027)
Table 106. India Postmenopausal Vaginal Atrophy Drugs Sales by Application (2016-2021) & (K Units)
Table 107. India Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Application (2016-2021)
Table 108. India Postmenopausal Vaginal Atrophy Drugs Sales by Application (2022-2027) & (K Units)
Table 109. India Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Application (2022-2027)
Table 110. Actavis plc Corporation Information
Table 111. Actavis plc Description and Business Overview
Table 112. Actavis plc Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Actavis plc Postmenopausal Vaginal Atrophy Drugs Product
Table 114. Actavis plc Recent Development
Table 115. Bionovo, Inc. Corporation Information
Table 116. Bionovo, Inc. Description and Business Overview
Table 117. Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Product
Table 119. Bionovo, Inc. Recent Development
Table 120. Endoceutics, Inc. Corporation Information
Table 121. Endoceutics, Inc. Description and Business Overview
Table 122. Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Product
Table 124. Endoceutics, Inc. Recent Development
Table 125. Novo Nordisk A/S Corporation Information
Table 126. Novo Nordisk A/S Description and Business Overview
Table 127. Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Product
Table 129. Novo Nordisk A/S Recent Development
Table 130. Pfizer Inc. Corporation Information
Table 131. Pfizer Inc. Description and Business Overview
Table 132. Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Product
Table 134. Pfizer Inc. Recent Development
Table 135. Teva Pharmaceuticals Ltd. Corporation Information
Table 136. Teva Pharmaceuticals Ltd. Description and Business Overview
Table 137. Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Product
Table 139. Teva Pharmaceuticals Ltd. Recent Development
Table 140. Therapeutics MD, Inc. Corporation Information
Table 141. Therapeutics MD, Inc. Description and Business Overview
Table 142. Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Product
Table 144. Therapeutics MD, Inc. Recent Development
Table 145. Shionogi & Company Corporation Information
Table 146. Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Shionogi & Company Description and Business Overview
Table 148. Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Product
Table 149. Shionogi & Company Recent Development
Table 150. Allergan plc Corporation Information
Table 151. Allergan plc Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Allergan plc Description and Business Overview
Table 153. Allergan plc Postmenopausal Vaginal Atrophy Drugs Product
Table 154. Allergan plc Recent Development
Table 155. Shionogi & Co. Ltd. Corporation Information
Table 156. Shionogi & Co. Ltd. Description and Business Overview
Table 157. Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Product
Table 159. Shionogi & Co. Ltd. Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Postmenopausal Vaginal Atrophy Drugs Distributors List
Table 163. Postmenopausal Vaginal Atrophy Drugs Customers List
Table 164. Postmenopausal Vaginal Atrophy Drugs Market Trends
Table 165. Postmenopausal Vaginal Atrophy Drugs Market Drivers
Table 166. Postmenopausal Vaginal Atrophy Drugs Market Challenges
Table 167. Postmenopausal Vaginal Atrophy Drugs Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Postmenopausal Vaginal Atrophy Drugs Product Picture
Figure 2. Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Application in 2021 & 2027
Figure 6. Vaginal Gels Examples
Figure 7. Creams Examples
Figure 8. Tablets Examples
Figure 9. Rings Examples
Figure 10. Patches Examples
Figure 11. Global Postmenopausal Vaginal Atrophy Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 13. Global Postmenopausal Vaginal Atrophy Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 14. Global Postmenopausal Vaginal Atrophy Drugs Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 15. Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 16. Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 17. North America Postmenopausal Vaginal Atrophy Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. North America Postmenopausal Vaginal Atrophy Drugs Sales (K Unit

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs